Last reviewed · How we verify
NCT03594474
Early Higher Intravenous Lipid Intake in VLBW Infants
NA trial testing Intravenous lipid emulsion in Very Low Birth Weight Infant in 83 participants. Completed in 19 October 2019.
8 July 2019
Quick facts
| Lead sponsor | Belal Alshaikh |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 83 |
| Start date | 15 August 2018 |
| Primary completion | 8 July 2019 |
| Estimated completion | 19 October 2019 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Intravenous lipid emulsion — full drug profile →
Conditions studied
- Very Low Birth Weight Infant — all drugs for Very Low Birth Weight Infant →
Sponsor
Belal Alshaikh
Who can join
Eligibility, any sex, with Very Low Birth Weight Infant. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Provision of high and early fat intake may help to reduce the amount of postnatal weight loss in Very Low Birth Weight Infants. It may also help utilize the high amount of protein that is currently recommended to these premature babies. Also, we expect babies who get this appropriate intake to regain their birth weight earlier than others who are on slow fat increase regimen.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
High Early Parenteral Lipid in Very Preterm Infants: A Randomized-Controlled Trial.
Alburaki W, Yusuf K, Dobry J, Sheinfeld R, et al · · 2021 · cited 21× · PMID 32798567 · DOI 10.1016/j.jpeds.2020.08.024
Verify or expand the search:
- PubMed search for NCT03594474
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Very Low Birth Weight Infant
Currently open trials in the same condition.
- NCT06555315 — Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic) · NA · recruiting
- NCT05308134 — Individualized Fortification of Human Milk for Infants Born ≤ 1250 g (MaxiMoM-InForM) · NA · recruiting
- NCT04640805 — Targeted Fortification of Pasteurized Donor Human Milk · NA · active not recruiting
- NCT05399667 — Assessment of Body Composition in Premature Children Submitted to an Early Stimulation Program · active not recruiting
- NCT04239508 — Swiss Neonatal Network & Follow-up Group · recruiting
Other Belal Alshaikh trials
Trials by the same sponsor.
- NCT03708068 — Early Exclusive Enteral Nutrition in Early Preterm Infants · NA · completed
- NCT03637413 — Effect of Hindmilk on Growth Velocity of Very Preterm Infants · NA · unknown
- NCT03422562 — Probiotics and Intestinal Microbiome in Preterm Infants · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03594474 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Belal Alshaikh
- Last refreshed: 21 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03594474.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing